Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol,
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal de Pediatria (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572019000100069 |
Resumo: | Abstract Objective: There is a scarcity of studies that assessed the association between adherence to combination therapy and asthma control in pediatric patients. The authors investigated the association between adherence to fluticasone propionate/salmeterol xinafoate combination-metered aerosol and the level of asthma control in children. Methods: This was a prospective observational study of 84 patients aged 5–16 years with moderate persistent asthma, who remained uncontrolled despite the use of 1000 µg/day of inhaled nonextrafine-hydrofluoric alkane-beclomethasone dipropionate in the three months prior to study enrollment. Participants were prescribed two daily doses of FP (125 µg)/salmeterol xinafoate (25 µg) combination by metered aerosol/spacer for six months. Adherence rates were assessed using the device's dose counter after the 2nd, 4th, and 6th months of follow up. Asthma control was assessed using a simplified Global Initiative for Asthma 2014 Report classification. Results: Mean adherence rates after the second, fourth, and sixth months were 87.8%, 74.9%, and 62.1% respectively, for controlled asthma, and 71.7%, 56.0%, and 47.6% respectively, for uncontrolled asthma (all p-values ≤ 0.03). The proportion of children achieving asthma control increased to 42.9%, 67.9% and 89.3% after the 2nd, 4th and 6th months of follow-up, respectively (p ≤ 0.001). Conclusion: Adherence rates between 87.8% in the 2nd month and 62.1% in the 6th month were strong determinants of asthma control. |
id |
SBPE-1_297c7bf21719a1a385fed830364e5cfd |
---|---|
oai_identifier_str |
oai:scielo:S0021-75572019000100069 |
network_acronym_str |
SBPE-1 |
network_name_str |
Jornal de Pediatria (Online) |
repository_id_str |
|
spelling |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol,AsthmaFluticasoneSalmeterolInhaled corticosteroidsAbstract Objective: There is a scarcity of studies that assessed the association between adherence to combination therapy and asthma control in pediatric patients. The authors investigated the association between adherence to fluticasone propionate/salmeterol xinafoate combination-metered aerosol and the level of asthma control in children. Methods: This was a prospective observational study of 84 patients aged 5–16 years with moderate persistent asthma, who remained uncontrolled despite the use of 1000 µg/day of inhaled nonextrafine-hydrofluoric alkane-beclomethasone dipropionate in the three months prior to study enrollment. Participants were prescribed two daily doses of FP (125 µg)/salmeterol xinafoate (25 µg) combination by metered aerosol/spacer for six months. Adherence rates were assessed using the device's dose counter after the 2nd, 4th, and 6th months of follow up. Asthma control was assessed using a simplified Global Initiative for Asthma 2014 Report classification. Results: Mean adherence rates after the second, fourth, and sixth months were 87.8%, 74.9%, and 62.1% respectively, for controlled asthma, and 71.7%, 56.0%, and 47.6% respectively, for uncontrolled asthma (all p-values ≤ 0.03). The proportion of children achieving asthma control increased to 42.9%, 67.9% and 89.3% after the 2nd, 4th and 6th months of follow-up, respectively (p ≤ 0.001). Conclusion: Adherence rates between 87.8% in the 2nd month and 62.1% in the 6th month were strong determinants of asthma control.Sociedade Brasileira de Pediatria2019-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572019000100069Jornal de Pediatria v.95 n.1 2019reponame:Jornal de Pediatria (Online)instname:Sociedade Brasileira de Pediatria (SBP)instacron:SBPE10.1016/j.jped.2017.10.008info:eu-repo/semantics/openAccessJentzsch,Nulma S.Silva,Gabriela C.G.Mendes,Guilherme M.S.Brand,Paul L.P.Camargos,Pauloeng2019-02-05T00:00:00Zoai:scielo:S0021-75572019000100069Revistahttp://www.jped.com.br/https://old.scielo.br/oai/scielo-oai.php||jped@jped.com.br1678-47820021-7557opendoar:2019-02-05T00:00Jornal de Pediatria (Online) - Sociedade Brasileira de Pediatria (SBP)false |
dc.title.none.fl_str_mv |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
title |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
spellingShingle |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, Jentzsch,Nulma S. Asthma Fluticasone Salmeterol Inhaled corticosteroids |
title_short |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
title_full |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
title_fullStr |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
title_full_unstemmed |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
title_sort |
Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol, |
author |
Jentzsch,Nulma S. |
author_facet |
Jentzsch,Nulma S. Silva,Gabriela C.G. Mendes,Guilherme M.S. Brand,Paul L.P. Camargos,Paulo |
author_role |
author |
author2 |
Silva,Gabriela C.G. Mendes,Guilherme M.S. Brand,Paul L.P. Camargos,Paulo |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Jentzsch,Nulma S. Silva,Gabriela C.G. Mendes,Guilherme M.S. Brand,Paul L.P. Camargos,Paulo |
dc.subject.por.fl_str_mv |
Asthma Fluticasone Salmeterol Inhaled corticosteroids |
topic |
Asthma Fluticasone Salmeterol Inhaled corticosteroids |
description |
Abstract Objective: There is a scarcity of studies that assessed the association between adherence to combination therapy and asthma control in pediatric patients. The authors investigated the association between adherence to fluticasone propionate/salmeterol xinafoate combination-metered aerosol and the level of asthma control in children. Methods: This was a prospective observational study of 84 patients aged 5–16 years with moderate persistent asthma, who remained uncontrolled despite the use of 1000 µg/day of inhaled nonextrafine-hydrofluoric alkane-beclomethasone dipropionate in the three months prior to study enrollment. Participants were prescribed two daily doses of FP (125 µg)/salmeterol xinafoate (25 µg) combination by metered aerosol/spacer for six months. Adherence rates were assessed using the device's dose counter after the 2nd, 4th, and 6th months of follow up. Asthma control was assessed using a simplified Global Initiative for Asthma 2014 Report classification. Results: Mean adherence rates after the second, fourth, and sixth months were 87.8%, 74.9%, and 62.1% respectively, for controlled asthma, and 71.7%, 56.0%, and 47.6% respectively, for uncontrolled asthma (all p-values ≤ 0.03). The proportion of children achieving asthma control increased to 42.9%, 67.9% and 89.3% after the 2nd, 4th and 6th months of follow-up, respectively (p ≤ 0.001). Conclusion: Adherence rates between 87.8% in the 2nd month and 62.1% in the 6th month were strong determinants of asthma control. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572019000100069 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572019000100069 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.jped.2017.10.008 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Pediatria |
publisher.none.fl_str_mv |
Sociedade Brasileira de Pediatria |
dc.source.none.fl_str_mv |
Jornal de Pediatria v.95 n.1 2019 reponame:Jornal de Pediatria (Online) instname:Sociedade Brasileira de Pediatria (SBP) instacron:SBPE |
instname_str |
Sociedade Brasileira de Pediatria (SBP) |
instacron_str |
SBPE |
institution |
SBPE |
reponame_str |
Jornal de Pediatria (Online) |
collection |
Jornal de Pediatria (Online) |
repository.name.fl_str_mv |
Jornal de Pediatria (Online) - Sociedade Brasileira de Pediatria (SBP) |
repository.mail.fl_str_mv |
||jped@jped.com.br |
_version_ |
1752122321769857024 |